COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Bo Hong

Dr. Bo Hong

Scientific Review Officer


Division of Translational and Clinical Sciences DTCS
Oncology 2 – Translational Clinical OTC
Study Section:
Radiation Therapeutics and Biology RTB

Dr. Bo Hong did her Ph.D. training in chemistry at Texas A&M University (1993) and her postdoctoral training at the University of Texas at Austin (1993-95). She came to NIH National Center for Research Resources Office of Review in 2003 and served as Scientific Review Officer (SRO) in the areas of biomedical technology and medical imaging. In 2004, she joined the CSR Oncological Sciences IRG and became SRO of the chartered Radiation Therapeutics and Biology study section as well as the recurring SBIR/STTR special emphasis panel ONC-R (11). She was a tenure-track faculty member at the University of California, Irvine for eight years before moving to NIH.